Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Acta Pharmaceutica Sinica
>
2014
>
49
>
11
Volume:
49
Issue:
11
1. Cloning and prokaryotic expression analysis of HDS from Salvia miltiorrhiza bge.f.alba.
Page:1614—1620
2. Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method.
Page:1607—1613
3. Preparation, formation mechanism and preliminary evaluation of oral absorption of a Bicyclol-phospholipid complex.
Page:1600—1606
4. Determination of γ-aminobutyric acid in human plasma by LC-MS/MS and its preliminary application to a human pharmacokinetic study.
Page:1593—1599
5. Effect of the chelator Zn-DTPA on the excretion of lead in lead intoxication mice detected with ICP-MS.
Page:1588—1592
6. Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats.
Page:1582—1587
7. Two new sesquiterpenoids from basidiomycete Tyromyces chioneus.
Page:1578—1581
8. Chemical constituents of bufadienolides in cinobufacino injection.
Page:1574—1577
9. The compounds from n-butanol fraction of Alpinia oxyphylla.
Page:1569—1573
10. Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans.
Page:1563—1568
11. Metformin ameliorates β-cell dysfunction by regulating inflammation production, ion and hormone homeostasis of pancreas in diabetic KKAy mice.
Page:1554—1562
12. Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro.
Page:1547—1553
13. Interaction of E3 ligase HUWE1 and eukaryotic translation initiation factor eIF4E.
Page:1543—1546
14. Embryo-fetus development toxicity of a novel PPAR-δ agonist in rat.
Page:1536—1542
15. Population pharmacokinetics of vancomycin and prediction of pharmacodynamics in the Chinese people.
Page:1528—1535
16. Progress in the study of Velvet and LaeA proteins and their relation to the development and bioactive compounds in medicinal fungi.
Page:1520—1527
17. The prospect of using bioinformatics technology in the field of biological medicine in the era of big data.
Page:1512—1519
18. Ribozyme riboswitch based gene expression regulation systems for gene therapy applications: progress and challenges.
Page:1504—1511
19. Thought and method of reproductive toxicity research in traditional Chinese medicine.
Page:1498—1503
20. Progress in the personalized medicine using pharmacometabonomics.
Page:1491—1497
21. Recent advances in curcumin and its derivatives for treatment of liver diseases.
Page:1483—1490
22. Recent advances in curcumin and its derivatives for treatment of liver diseases.
Page:1483—90
23. Progress in the personalized medicine using pharmacometabonomics.
Page:1491—7
24. Thought and method of reproductive toxicity research in traditional Chinese medicine.
Page:1498—503
25. Ribozyme riboswitch based gene expression regulation systems for gene therapy applications: progress and challenges.
Page:1504—11
26. The prospect of using bioinformatics technology in the field of biological medicine in the era of big data.
Page:1512—9
27. Progress in the study of Velvet and LaeA proteins and their relation to the development and bioactive compounds in medicinal fungi.
Page:1520—7
28. Population pharmacokinetics of vancomycin and prediction of pharmacodynamics in the Chinese people.
Page:1528—35
29. Embryo-fetus development toxicity of a novel PPAR-δ agonist in rat.
Page:1536—42
30. Interaction of E3 ligase HUWE1 and eukaryotic translation initiation factor eIF4E.
Page:1543—6
31. Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro.
Page:1547—53
32. Metformin ameliorates β-cell dysfunction by regulating inflammation production, ion and hormone homeostasis of pancreas in diabetic KKAy mice.
Page:1554—62
33. Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans.
Page:1563—8
34. The compounds from n-butanol fraction of Alpinia oxyphylla.
Page:1569—73
35. Chemical constituents of bufadienolides in cinobufacino injection.
Page:1574—7
36. Two new sesquiterpenoids from basidiomycete Tyromyces chioneus.
Page:1578—81
37. Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats.
Page:1582—7
38. Effect of the chelator Zn-DTPA on the excretion of lead in lead intoxication mice detected with ICP-MS.
Page:1588—92
39. Determination of γ-aminobutyric acid in human plasma by LC-MS/MS and its preliminary application to a human pharmacokinetic study.
Page:1593—9
40. Preparation, formation mechanism and preliminary evaluation of oral absorption of a Bicyclol-phospholipid complex.
Page:1600—6
41. Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method.
Page:1607—13
42. Cloning and prokaryotic expression analysis of HDS from Salvia miltiorrhiza bge.f.alba.
Page:1614—20
